Trials / Completed
CompletedNCT05709756
Prevalence and Predictors of Esophageal Thermal Lesions in High-power-Short-duration Ablation of Atrial Fibrillation
Prevalence and Predictors of Esophageal Thermal Lesions in High-Power-Short-Duration Ablation of Atrial Fibrillation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 263 (actual)
- Sponsor
- Helios Health Institute GmbH · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Patients with documented atrial fibrillation who were referred to our clinic for catheter ablation will undergo standard HPSD ablation and subsequent esophagoscopy. After esophagoscopy patients will be followed up for one month in the form of a telephone follow-up. The primary endpoint of the study assessed by esophagoscopy performed on the day after the index catheter ablaton is the incidence of esophageal thermal lesions. Secondary endpoints include: 1. The size of the esophageal thermal lesions. 2. The severity of esophageal thermal lesions.
Conditions
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2023-08-01
- Completion
- 2023-09-01
- First posted
- 2023-02-02
- Last updated
- 2023-10-02
Locations
2 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT05709756. Inclusion in this directory is not an endorsement.